Laporan Kasus : Penanganan Fibrilasi Atrium Perioperatif

Roy Lizal; I Wayan Suranadi

doi:10.15562/medicina.v52i3.1086

Laporan Kasus : Penanganan Fibrilasi Atrium Perioperatif

Roy Lizal ,

I Wayan Suranadi ,

pdf |
DOI: https://doi.org/10.15562/medicina.v52i3.1086 |
Published: 2021-10-05

Abstract

Atrial fibrillation (AF) is the commonest cardiac arrhythmia; its incidence increases with age. Diabetes mellitus, hypertension and ventricular hypertrophy are commonly associated with non-valvular atrial fibrillation. Primary aims of management of AF are conversion to sinus rhythm, maintenance of sinus rhythm and prevention of thromboembolic complications. In elderly patients who are asymptomatic, adequate rate control of AF appears to offer the same benefits as rhythm control. Chronic AF carries a high risk of ischaemic stroke from thromboembolism; all patients at risk must receive adequate anticoagulation. Anticoagulation should be continued in patients with risk factors despite successful conversion to sinus rhythm.

Fibrilasi atrium adalah aritmia jantung yang paling sering dijumpai. Kejadian fibrilasi atrium meningkat seiring bertambahnya usia. Diabetes mellitus, hipertensi, dan hipertrofi ventrikel biasanya dikaitkan dengan fibrilasi atrium non-katup. Tujuan utama penatalaksanaan fibrilasi atrium adalah konversi ke irama sinus, pemeliharaan irama sinus, dan pencegahan komplikasi tromboemboli. Pada pasien usia lanjut yang asimptomatik, kontrol denyut nadi yang baik memberikan manfaat yang sama seperti kontrol ritme. Fibrilasi atrium kronis beresiko tinggi menimbulkan stroke iskemik akibat tromboemboli. Semua pasien yang berisiko harus menerima antikoagulan yang adekuat. Antikoagulan harus dilanjutkan pada pasien dengan faktor risiko meskipun telah dilakukan konversi menjadi irama sinus. Pada laporan kasus ini akan dibahas mengenai pasien dengan fibrilasi atrium yang akan menjalani operasi dekompresi stabilisasi fusi.

References

Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, dkk. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370-5.
European Heart Rhythm Association, European Association for CardioThoracic Surgery, Camm AJ, Kirchhoff P, Lip GY, Schotten U, dkk. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369-429.
Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D’Agostino RB. Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J. 1996;131(4):790-5.
Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, dkk. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347(23):1825-33
Stewart S, Murphy NF, Walker A, McGuire A, McMurray JJ. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart 2004;90(3):286-92.
Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnioser SH, dkk. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719-47.
Issa ZF. Atrial Fibrillation. In: Miller JM, Zipes DP, eds. Clinical arrhythmology and electrophysiology: a companion to Braunwald’s heart disease. Edisi 2. Philadelphia: Saunders; 2012.
Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation 2002;105(23):2753-9.
Po SS, Scherlag BJ, Yamanashi WS, Edwards J, Zhou J, Wu R, dkk. Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions. Heart Rhythm. 2006;3(2):201-8. 114 | Pedoman Fibrilasi Atrium Non-valvular PERKI 2019
Daoud EG, Bogun F, Goyal R, Harvey M, Man KC, Strickberger SA, dkk. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation 1996;94(7):1600-6.

[1] Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, dkk. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370-5.

[2] European Heart Rhythm Association, European Association for CardioThoracic Surgery, Camm AJ, Kirchhoff P, Lip GY, Schotten U, dkk. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31(19):2369-429.

[3] Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D’Agostino RB. Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J. 1996;131(4):790-5.

[4] Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, dkk. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347(23):1825-33

[5] Stewart S, Murphy NF, Walker A, McGuire A, McMurray JJ. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart 2004;90(3):286-92.

[6] Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnioser SH, dkk. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719-47.

[7] Issa ZF. Atrial Fibrillation. In: Miller JM, Zipes DP, eds. Clinical arrhythmology and electrophysiology: a companion to Braunwald’s heart disease. Edisi 2. Philadelphia: Saunders; 2012.

[8] Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation 2002;105(23):2753-9.

[9] Po SS, Scherlag BJ, Yamanashi WS, Edwards J, Zhou J, Wu R, dkk. Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions. Heart Rhythm. 2006;3(2):201-8. 114 | Pedoman Fibrilasi Atrium Non-valvular PERKI 2019

[10] Daoud EG, Bogun F, Goyal R, Harvey M, Man KC, Strickberger SA, dkk. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation 1996;94(7):1600-6.

Laporan Kasus : Penanganan Fibrilasi Atrium Perioperatif

Abstract

References

How to Cite

Search Panel